Pilot study of tocilizumab monotherapy for active chronic periaortitis

OBJECTIVES: To investigate the effectiveness and safety of TCZ (tocilizumab) monotherapy for chronic periaortitis (CP) patients at acute active stage. METHODS: Twelve patients with definite or possible diagnosis of CP were enrolled and received intravenous infusions of TCZ (8 mg/kg) every 4 weeks fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Anqi, Peng, Linyi, Zhou, Jiaxin, Liu, Zheng, Lu, Hui, Peng, Yu, Li, Jieqiong, Fei, Yunyun, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069601/
https://www.ncbi.nlm.nih.gov/pubmed/36977534
http://dx.doi.org/10.1136/rmdopen-2023-003007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069601/
https://www.ncbi.nlm.nih.gov/pubmed/36977534
http://dx.doi.org/10.1136/rmdopen-2023-003007

Ejemplares similares